Roctavian, the First Gene Therapy Treatment for Hemophilia A
By: Paulina Maczko, PharmD Candidate 2027, Sarah El-Rowmeim, PharmD Candidate 2027, and Laura Pham, PharmD Candidate 2025 Valoctocogene roxaparvovec-rvox, sold…
FDA Approves New Weight Loss Injectable, Zepbound™
By: Katelyn Hoosein, PharmD Candidate c/o 2025 and My Tram (Sophie) Le, PharmD Candidate c/o 2028 In recent years, there has…
The First Lab-Grown Blood Transfusion
By: John Ortiz, PharmD Candidate c/o 2025 What is a Blood Transfusion? A blood transfusion is a procedure where donated…
Pharmacy Benefit Managers 2023 Update
By: Giavanna Carr, PharmD Candidate c/o 2025 In March of 2023, Senators Maria Cantwell and Charles E. Grassley successfully passed…
FDA Approves Bimzelx® for the Treatment of Moderate to Severe Plaque Psoriasis
By: Bhojranie Brahmanand, PharmD Candidate c/o 2025 On October 18, 2023, the United States Food and Drug Administration (FDA) approved…
The “Morning-After” Antibiotic
By: Anureet Kaur, PharmD Candidate c/o 2024 According to surveillance data from the United States Centers for Disease Control and…
6th Year Perspective: From Pharmacy Student to Pfizer Fellow
Featuring: Frances Alexis Dela Cruz, PharmD Candidate c/o 2024 By: Celestine Van Sertima, PharmD Candidate c/o 2027 Frances Alexis Dela…
An Oral Revolution in Treating Adults Diagnosed with Type II Diabetes Mellitus
By: Samia Rahman Adity, PharmD Candidate c/o 2025 Diabetes Facts and Statistics Type II diabetes (T2D) has been a consequential…
FDA Approves Jardiance® for the Treatment of Adults with Chronic Kidney Disease
By: Urooj K. Malik, PharmD Candidate c/o 2024 Effective September 22, 2023, the United States (U.S.) Food and Drug Administration…
Rho Chi Talks: Interview with the CEO of Cullinan Oncology
Featuring: Nadim Ahmed, President and CEO, Cullinan Oncology By: Sairah Skeikh, PharmD Candidate c/o 2024 Nadim Ahmed is the President…